Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Italiano, A
Right arrow Articles by Thyss, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Italiano, A
Right arrow Articles by Thyss, A
Haematologica, Vol 90, Issue 9, 1281-1283
Copyright © 2005 by Ferrata Storti Foundation

Comparative Study

Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old

A Italiano, F Jardin, F Peyrade, L Saudes, H Tilly, and A Thyss

Treatment of very old patients with non-Hodgkin's lymphoma remains controversial. Indeed, patients over 80 years old are usually not included in trials. We show here that addition of rituximab to reduced-dose CHOP chemotherapy seems to be a good compromise between toxicity and efficacy, allowing clinicians to treat very elderly patients with a curative intent.


This article has been cited by other articles:


Home page
 JCOHome page
C. Thieblemont and B. Coiffier
Lymphoma in Older Patients
J. Clin. Oncol., May 10, 2007; 25(14): 1916 - 1923.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.